Molecularly targeted therapies in non-small-cell lung cancer annual update 2014
作者： Daniel Morgensztern , Meghan J Campo , Suzanne E Dahlberg , Robert C Doebele , Edward Garon
DOI: 10.1097/JTO.0000000000000405
关键词:
摘要: There have been significant advances in the understanding of the biology and treatment of non–small-cell lung cancer (NSCLC) during the past few years. A number of molecularly …
jto.org
elsevier.com
utsystem.edu参考文章(322)
Mitsudomi T, Minna Jd, Gazdar Af, Mulshine Jl, Viallet J, Linnoila Ri, Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines Oncogene. ,vol. 6, pp. 1353- 1362 ,(1991)
Ozgur Cem Erkin, Jhingook Kim, Jin Seok Ahn, Jungsuk An, Myung Ju Ahn, Jinwon Seo, Keunchil Park, Young Mog Shim, Young Kee Shin, Yoon La Choi, Kyung Song, Sanghui Park, Chang Ok Sung, Joungho Han, High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients. Histology and Histopathology. ,vol. 27, pp. 197- 207 ,(2012) , 10.14670/HH-27.197
Ian J Majewski, Lorenza Mittempergher, Nadia M Davidson, Astrid Bosma, Stefan M Willems, Hugo M Horlings, Iris de Rink, Liliana Greger, Gerrit KJ Hooijer, Dennis Peters, Petra M Nederlof, Ingrid Hofland, Jeroen de Jong, Jelle Wesseling, Roelof JC Kluin, Wim Brugman, Ron Kerkhoven, Frank Nieboer, Paul Roepman, Annegien Broeks, Thomas R Muley, Jacek Jassem, Jacek Niklinski, Nico van Zandwijk, Alvis Brazma, Alicia Oshlack, Michel van den Heuvel, René Bernards, Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing. The Journal of Pathology. ,vol. 230, pp. 270- 276 ,(2013) , 10.1002/PATH.4209
, A genomics-based classification of human lung tumors Science Translational Medicine. ,vol. 5, pp. 1- 28 ,(2013) , 10.1126/SCITRANSLMED.3006802
Mizuki Nishino, Suzanne E. Dahlberg, Stephanie Cardarella, David M. Jackman, Michael S. Rabin, Nikhil H. Ramaiya, Hiroto Hatabu, Pasi A. Jänne, Bruce E. Johnson, Volumetric tumor growth in advanced non‐small cell lung cancer patients with EGFR mutations during EGFR‐tyrosine kinase inhibitor therapy Cancer. ,vol. 119, pp. 3761- 3768 ,(2013) , 10.1002/CNCR.28290
Weijing Cai, Chunxia Su, Xuefei Li, Lihong Fan, Limou Zheng, Ke Fei, Caicun Zhou, KIF5B-RET fusions in Chinese patients with non–small cell lung cancer†‡ Cancer. ,vol. 119, pp. 1486- 1494 ,(2013) , 10.1002/CNCR.27940
Jan Hm Schellens., Dana Ghiorghiu, Paul K. Stockman, Elaine Kilgour, Andrew Hastie, Andrea Varga, Ruud Van der Noll, Paul D. Smith, Peter Lawrence, Merran Macpherson, Emma Dean, Malcolm Ranson, Fabrice Andre, Results of a phase I study of AZD4547, an inhibitor of fibroblast growth factor receptor (FGFR), in patients with advanced solid tumors In: American Association for Cancer Research; 06 Apr 2013-10 Apr 2013; Walter E. Washington Convention Center, Washington, DC. 2013.. ,(2013)
Jeeyun Lee, Seung Eun Lee, So Young Kang, In-Gu Do, Sujin Lee, Sang Yun Ha, Jeonghee Cho, Won Ki Kang, Jiryeon Jang, Sai-Hong Ignatius Ou, Kyoung-Mee Kim, Identification of ROS1 rearrangement in gastric adenocarcinoma Cancer. ,vol. 119, pp. 1627- 1635 ,(2013) , 10.1002/CNCR.27967
Sjoerd Rodenhuis, Robert J. C. Slebos, Clinical significance of ras oncogene activation in human lung cancer. Cancer Research. ,vol. 52, pp. 2665- 2669 ,(1992)
Joyce J. F. J. Bos, ras Oncogenes in Human Cancer: A Review Cancer Research. ,vol. 49, pp. 4682- 4689 ,(1989)